Thalidomide for previously untreated indolent or smoldering multiple myeloma
Open Access
- 26 July 2001
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 15 (8) , 1274-1276
- https://doi.org/10.1038/sj.leu.2402183
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myelomaCancer Treatment Reviews, 2000
- Thalidomide in the Treatment of Relapsed Multiple MyelomaMayo Clinic Proceedings, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myelomaLeukemia, 1999
- Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of NeovascularizationExperimental Eye Research, 1997
- Multiple MyelomaNew England Journal of Medicine, 1997
- Bone marrow angiogenesis and progression in multiple myelomaBritish Journal of Haematology, 1994
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Smoldering Multiple MyelomaNew England Journal of Medicine, 1980